Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches

Table 3

The difference in median tissue (VCAM-1, MCP-1, and TNF alpha) immunostain intensity between normal control (NC), atherogenic control (AC), vehicle control (VC), and clopidogrel treated groups.

Markers	Groups
	Clopidogrel treated	AC	NC	VC
VCAM-1	Moderate**	Very strong*	Negative	Very strong*
MCP-1	Moderate**	Very strong*	Negative	Very strong*
TNF𝛼	Moderate**	Very strong*	Negative	Very strong*
IL-17 A	Moderate**	Very strong*	Negative	Very strong*

^∗𝑃<0.05, as compared to NC group.
^∗∗𝑃<0.05, as compared to AC group.